Effect of the nurse‐led Hospital Elder Life Program on delirium reduction among delirious patients with COVID‐19: A randomized clinical trial

Author:

Ni Yun‐Xia1ORCID,Hu Zi‐Yi2,Wang Rui‐Li3,Huang Yan3,Jiang Yang‐Yang3,Wang Hai‐Yan3,Ruan Shun‐Li3,Zhou Dong4,Chen Qian3,Jiang Yan2ORCID

Affiliation:

1. Department of Cardiology, West China Hospital, Sichuan University/West China School of Nursing Sichuan University Chengdu China

2. Department of Nursing, West China Hospital, Sichuan University/West China School of Nursing Sichuan University Chengdu China

3. Center of Gerontology and Geriatrics, West China Hospital, Sichuan University/West China School of Nursing Sichuan University Chengdu China

4. Department of Neurology, West China Hospital Sichuan University Chengdu China

Abstract

AbstractBackgroundInfectious diseases, such as COVID‐19, are high‐risk factors for delirium. However, the implementation of nonpharmacological interventions faces major challenges during an infectious disease pandemic.AimsTo evaluate the effect of the nurse‐led Hospital Elder Life Program (NL‐HELP) on delirium reduction among delirious patients with COVID‐19.DesignA single‐blind randomized clinical trial.MethodsThis study recruited 122 delirious patients with COVID‐19 from internal medicine wards at West China Hospital in China between January 30 and March 31, 2023. Participants were randomized to the NL‐HELP group (n = 62) or the usual care group (n = 60). Patients in the intervention group received the NL‐HELP protocol three times daily for 7 days. Patients in the control group received usual care. The primary outcome was the absence/presence of delirium during the intervention period measured by the 3‐min Diagnostic Confusion Assessment Method.ResultsFewer patients remained delirious in the NL‐HELP group than in the control group. There were significantly more delirium‐free days in the NL‐HELP group than in the usual care group. There were no statistically significant differences between the two groups in terms of delirium severity, length of hospital stay, delirium at 30 days after discharge, 30‐day readmission, 30‐day mortality, physical function or quality of life.ConclusionsThis study demonstrated that NL‐HELP could reduce the presence of delirium in delirious patients. No effect was observed in terms of shortening the length of hospital stay, reducing 30‐day mortality, or improving quality of life.ImpactNL‐HELP may be effective in reducing the presence of delirium in delirious patients. Further research is needed to determine whether the NL‐HELP can improve patient outcomes (e.g. mortality and quality of life) in a larger study.Patient or Public ContributionCaregivers of delirious patients were invited to provide intervention strategies to prevent or abate delirium, including environmental management, orientation communications and identification of alert signs.Trial RegistrationThis study was prospectively registered at the Chinese Clinical Trial Registry (https://www.chictr.org.cn/) Identifier: ChiCTR2300067874.

Funder

National Key Research and Development Program of China

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3